Entry |
|
Name |
Regulation of actin cytoskeleton - Homo sapiens (human) |
Class |
Cellular Processes; Cell motility
|
Pathway map |
hsa04810 | Regulation of actin cytoskeleton |
|
Network |
|
Element |
N00405 | CXCR4-GNA12/13-Rho signaling pathway |
N01068 | ITGA/B-FAK-RAC signaling pathway |
N01097 | LPA-GNA12/13-RhoA signaling pathway |
N01768 | CXCR4-GNA12/13 signaling pathway |
|
Drug |
D01175 | Carpronium chloride (JAN/INN) |
D01840 | Fasudil hydrochloride (JAN) |
D03115 | Fasudil hydrochloride hydrate (JAN) |
D03722 | Efegatran sulfate (USAN) |
D04492 | Icatibant acetate (JAN/USAN) |
D09342 | Etaracizumab (USAN/INN) |
D09752 | Carpronium chloride hydrate (JAN) |
D10028 | Valategrast hydrochloride (USAN) |
D10392 | Lifitegrast sodium (USAN) |
D10463 | Ripasudil hydrochloride hydrate (JAN) |
|
Other DBs |
|
Organism |
Homo sapiens (human) [GN: hsa]
|
Gene |
1902 | LPAR1; lysophosphatidic acid receptor 1 [KO:K04289] |
9170 | LPAR2; lysophosphatidic acid receptor 2 [KO:K04291] |
2846 | LPAR4; lysophosphatidic acid receptor 4 [KO:K04275] |
57121 | LPAR5; lysophosphatidic acid receptor 5 [KO:K08390] |
6387 | CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031] |
7852 | CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189] |
2149 | F2R; coagulation factor II thrombin receptor [KO:K03914] |
8822 | FGF17; fibroblast growth factor 17 [KO:K04358] |
2255 | FGF10; fibroblast growth factor 10 [KO:K04358] |
8823 | FGF16; fibroblast growth factor 16 [KO:K04358] |
8817 | FGF18; fibroblast growth factor 18 [KO:K04358] |
9965 | FGF19; fibroblast growth factor 19 [KO:K22603] |
8074 | FGF23; fibroblast growth factor 23 [KO:K22428] |
5154 | PDGFA; platelet derived growth factor subunit A [KO:K04359] |
5155 | PDGFB; platelet derived growth factor subunit B [KO:K17386] |
56034 | PDGFC; platelet derived growth factor C [KO:K05450] |
80310 | PDGFD; platelet derived growth factor D [KO:K05450] |
3674 | ITGA2B; integrin subunit alpha 2b [KO:K06476] |
8515 | ITGA10; integrin subunit alpha 10 [KO:K06586] |
623 | BDKRB1; bradykinin receptor B1 [KO:K03915] |
624 | BDKRB2; bradykinin receptor B2 [KO:K03916] |
1128 | CHRM1; cholinergic receptor muscarinic 1 [KO:K04129] |
1129 | CHRM2; cholinergic receptor muscarinic 2 [KO:K04130] |
1131 | CHRM3; cholinergic receptor muscarinic 3 [KO:K04131] |
1132 | CHRM4; cholinergic receptor muscarinic 4 [KO:K04132] |
1133 | CHRM5; cholinergic receptor muscarinic 5 [KO:K04133] |
731 | C8A; complement C8 alpha chain [KO:K03997] |
732 | C8B; complement C8 beta chain [KO:K03998] |
733 | C8G; complement C8 gamma chain [KO:K03999] |
2768 | GNA12; G protein subunit alpha 12 [KO:K04346] |
2245 | FGD1; FYVE, RhoGEF and PH domain containing 1 [KO:K05720] |
89846 | FGD3; FYVE, RhoGEF and PH domain containing 3 [KO:K05722] |
9564 | BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726] |
1398 | CRK; CRK proto-oncogene, adaptor protein [KO:K04438] |
1399 | CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438] |
1793 | DOCK1; dedicator of cytokinesis 1 [KO:K13708] |
6654 | SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099] |
6655 | SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099] |
3265 | HRAS; HRas proto-oncogene, GTPase [KO:K02833] |
3845 | KRAS; KRAS proto-oncogene, GTPase [KO:K07827] |
4893 | NRAS; NRAS proto-oncogene, GTPase [KO:K07828] |
9459 | ARHGEF6; Rac/Cdc42 guanine nucleotide exchange factor 6 [KO:K05729] |
5290 | PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153] |
5293 | PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153] |
5291 | PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153] |
5295 | PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649] |
5296 | PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649] |
8503 | PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649] |
10451 | VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730] |
7409 | VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730] |
7410 | VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730] |
7074 | TIAM1; TIAM Rac1 associated GEF 1 [KO:K05731] |
9138 | ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330] |
23365 | ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532] |
2909 | ARHGAP35; Rho GTPase activating protein 35 [KO:K05732] |
387 | RHOA; ras homolog family member A [KO:K04513] |
998 | CDC42; cell division cycle 42 [KO:K04393] |
8874 | ARHGEF7; Rho guanine nucleotide exchange factor 7 [KO:K13710] |
4659 | PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270] |
4660 | PPP1R12B; protein phosphatase 1 regulatory subunit 12B [KO:K12329] |
54776 | PPP1R12C; protein phosphatase 1 regulatory subunit 12C [KO:K17457] |
1729 | DIAPH1; diaphanous related formin 1 [KO:K05740] |
1730 | DIAPH2; diaphanous related formin 2 [KO:K05741] |
6548 | SLC9A1; solute carrier family 9 member A1 [KO:K05742] |
23396 | PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [KO:K00889] [EC:2.7.1.68] |
8394 | PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [KO:K00889] [EC:2.7.1.68] |
8395 | PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1 beta [KO:K00889] [EC:2.7.1.68] |
5305 | PIP4K2A; phosphatidylinositol-5-phosphate 4-kinase type 2 alpha [KO:K00920] [EC:2.7.1.149] |
10458 | BAIAP2; BAR/IMD domain containing adaptor protein 2 [KO:K05627] |
8976 | WASL; WASP like actin nucleation promoting factor [KO:K23612] |
23191 | CYFIP1; cytoplasmic FMR1 interacting protein 1 [KO:K05749] |
26999 | CYFIP2; cytoplasmic FMR1 interacting protein 2 [KO:K05749] |
3071 | NCKAP1L; NCK associated protein 1 like [KO:K05750] |
55845 | BRK1; BRICK1 subunit of SCAR/WAVE actin nucleating complex [KO:K05752] |
10095 | ARPC1B; actin related protein 2/3 complex subunit 1B [KO:K05757] |
10552 | ARPC1A; actin related protein 2/3 complex subunit 1A [KO:K05757] |
10109 | ARPC2; actin related protein 2/3 complex subunit 2 [KO:K05758] |
10094 | ARPC3; actin related protein 2/3 complex subunit 3 [KO:K05756] |
10093 | ARPC4; actin related protein 2/3 complex subunit 4 [KO:K05755] |
10092 | ARPC5; actin related protein 2/3 complex subunit 5 [KO:K05754] |
81873 | ARPC5L; actin related protein 2/3 complex subunit 5 like [KO:K05754] |
8826 | IQGAP1; IQ motif containing GTPase activating protein 1 [KO:K16848] |
10788 | IQGAP2; IQ motif containing GTPase activating protein 2 [KO:K05767] |
128239 | IQGAP3; IQ motif containing GTPase activating protein 3 [KO:K05767] |
324 | APC; APC regulator of WNT signaling pathway [KO:K02085] |
10297 | APC2; APC regulator of WNT signaling pathway 2 [KO:K02085] |
50649 | ARHGEF4; Rho guanine nucleotide exchange factor 4 [KO:K05769] |
|
Compound |
C00681 | 1-Acyl-sn-glycerol 3-phosphate |
C04637 | 1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate |
C05981 | Phosphatidylinositol-3,4,5-trisphosphate |
C11554 | 1-Phosphatidyl-1D-myo-inositol 3,4-bisphosphate |
|
Reference |
|
Authors |
Burridge K, Wennerberg K. |
Title |
Rho and Rac take center stage. |
Journal |
|
Reference |
|
Authors |
Schmitz AA, Govek EE, Bottner B, Van Aelst L. |
Title |
Rho GTPases: signaling, migration, and invasion. |
Journal |
|
Reference |
|
Authors |
Takai Y, Sasaki T, Matozaki T. |
Title |
Small GTP-binding proteins. |
Journal |
|
Reference |
|
Authors |
Pollard TD. |
Title |
The cytoskeleton, cellular motility and the reductionist agenda. |
Journal |
|
Reference |
|
Authors |
Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. |
Title |
Cell migration: integrating signals from front to back. |
Journal |
|
Reference |
|
Authors |
Sastry SK, Burridge K. |
Title |
Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. |
Journal |
|
Reference |
|
Authors |
Fukata M, Nakagawa M, Kuroda S, Kaibuchi K. |
Title |
Cell adhesion and Rho small GTPases. |
Journal |
J Cell Sci 112 ( Pt 24):4491-500 (1999) |
Related pathway |
|
KO pathway |
|